IOTA’s Business Development offices are based in the St Johns Innovation Centre in Cambridge.

We offer business connectivity in the fragment-based drug design area to drug discovery companies, large and small. Led by IOTA co-Founder Dr David Bailey, the business team has extensive experience working with large and small pharma, as well as international biotech companies.